天然产物研究与开发 ›› 2023, Vol. 35 ›› Issue (增刊1): 10-15.

• 研究论文 • 上一篇    下一篇

畲药十二时辰总皂苷对CCl4致小鼠肝纤维化的保护作用

沈锦煌1,冯是标1,杨娜娜1,马新华1,钟添华2,张永红1*   

  1. 1福建医科大学药学院,福州350122;2自然资源部第三海洋研究所,厦门361006
  • 出版日期:2023-06-28 发布日期:2023-06-13
  • 基金资助:
    国家自然科学基金(41806173);自然资源部海洋三所海洋生物遗传资源重点实验室开放课题(HY201807);福建省科技创新平台项目(2018Y2001);福建省自然科学基金项目(2020J01619) 

Protective effect of total saponins of Clematis florida Thunb.var. plena on CCl4-induced hepatic fibrosis in mice

SHEN Jin-huang1,FENG Shi-biao1,YANG Na-na1,MA Xin-hua1,ZHONG Tian-hua2,ZHANG Yong-hong1*   

  1. 1College of Pharmacy,Fujian Medical University,Fuzhou 350122,China;2Third Institute of Oceanography,State Oceanic Administration,Xiamen 361006,China
  • Online:2023-06-28 Published:2023-06-13

摘要:

研究畲药十二时辰(Clematis florida Thunb.var. plena)总皂苷对四氯化碳(CCl4)诱导的小鼠肝纤维化的保护作用及其机制。将50只ICR雄性小鼠随机分为正常组、模型组、联苯双酯组和畲药十二时辰总皂苷(SCFP)低高剂量组。除正常组外其余各组腹腔注射CCl4溶液进行造模。造模结束后,除模型组和正常组灌胃0.1%CMC-Na水溶液外,各药物组按剂量灌胃给予受试药物,末次给药后采集血液和肝脏组织。HE和Masson染色观察各组肝脏病理组织学变化;生化试剂盒和ELISA试剂盒检测血清中谷草转氨酶(AST)和谷丙转氨酶(ALT)的含量及人Ⅰ型胶原(Col Ⅰ)和人Ⅲ型胶原(Col Ⅲ)的表达水平;肝脏中丙二醛(MDA)、超氧化物歧化酶(SOD)、谷胱甘肽(GSH)和一氧化氮(NO)的含量;用免疫组化染色检测小鼠肝脏中转化生长因子-β1(TGF-β1)和α-平滑肌肌动蛋白(α-SMA)的表达水平;用Western blot法检测肝脏中TGF-β1、基质金属蛋白酶-9(MMP-9)、α-SMA和SMAD2的蛋白表达量。结果显示,与模型组相比,SCFP给药后肝组织破坏程度降低,肝细胞变性程度减轻,胶原沉积也显著减少;SCFP组小鼠血清中ALT和AST水平显著降低、血清中纤维化相关因子Col Ⅰ和Col Ⅲ显著性下降,且肝脏组织中TGF-β、MMP-9、α-SMA、TGF-β1和SMAD2表达显著下降;而肝脏中抗氧化指标SOD和GSH显著性上升、MDA和NO显著性下降。本研究结果表明,畲药十二时辰总皂苷具有抗肝纤维化作用,其机制可能与其减少细胞间质胶原沉积,提高肝脏抗氧化能力和调节TGF-1/Smad信号通路相关蛋白的表达密切相关。

关键词: 畲药十二时辰总皂苷, 肝纤维化, 四氯化碳, 抗氧化

Abstract:

To study the protective effect and mechanism of the total saponins from the roots of Clematis florida Thunb. var. plena on CCl4-induced hepatic fibrosis in mice.Fifty ICR male mice were randomly divided into normal group,model group,bifendatatum group and total saponins of Clematis florida Thunb. var. plena (SCFP) low and high dose groups.Except for the normal group,the mice in the other groups were injected with CCl4 solution by intraperitoneal injection.Except for the model group and the normal group,each drug group was given the same dose of 0.1% CMC-Na aqueous solution by intragastric administration.After the last administration,blood and liver tissue of mice were collected.HE and Masson staining were used to observe the histopathological changes of the liver in each group;the contents of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) in serum and the expression levels of human collagen type Ⅰ (Col Ⅰ) and human collagen type Ⅲ (Col Ⅲ) in serum were detected by biochemical kits and ELISA kits;the contents of malondialdehyde (MDA),superoxide dismutase (SOD),glutathione (GSH) and nitric oxide (NO) in liver;the expression levels of transforming growth factor-β (TGF-β1) and α-smooth muscle actin (α-SMA) in the liver of mice were detected by immunohistochemical staining;the protein expressions of TGF-β1,matrix metalloprotein-9 (MMP-9),α-SMA and SMAD2 in the liver were detected by Western blot.The results showed that compared with the model group,the SCFP group decreased the degree of liver tissue damage,the degree of hepatocyte degeneration,and significantly decreased collagen deposition,and the serum ALT and AST levels of the mice in the SCFP group was significantly decreased,and the serum fibrosis-related factors Col I and Col Ⅲ was significantly decreased;the expressions of TGF-β1,MMP-9,α-SMA,TGF-β1 and SMAD2 in liver tissue were significantly decreased;the antioxidant indexes SOD and GSH in liver increased significantly,while MDA and NO decreased significantly.The results of this study show that SCFP have anti-hepatic fibrosis effects,and the mechanism may be closely related to reducing the deposition of interstitial collagen,improving the antioxidant capacity of the liver and regulating the expression of TGF-1/Smad signaling pathway-related proteins.

Key words: total saponins of Clematis florida Thunb.var. plena, hepatic fibrosis, carbon tetrachloride, antioxidant

中图分类号:  R285.5